Communication Bridge‐2 randomized controlled trial: Recruitment and baseline features
Primary progressive aphasia (PPA) negatively impacts communication participation. Communication Bridge-2 (CB2) is a telemedicine-delivered randomized controlled trial. CB2 included global recruitment and randomization of 95 PPA participant dyads. CB2, the first international superiority trial for PPA using video chat shows feasibility. The study provides a model for rigorous non-pharmacologic trials for Alzheimer's disease and related dementias.
Authors
- Melanie Fried‐Oken (ORCID: https://orcid.org/0000-0002-5075-8392)
- Michele Bona (ORCID: https://orcid.org/0000-0002-8465-281X)
- Marissa Esparza
- Aimee Mooney (ORCID: https://orcid.org/0000-0002-3642-8995)
- Alfred Rademaker (ORCID: https://orcid.org/0000-0003-3103-6519)
- Emily Rogalskı (ORCID: https://orcid.org/0000-0002-6472-1363)
- Angela Roberts (ORCID: https://orcid.org/0000-0002-9226-8009)
Institutions
- Northwestern University (US)
- Western University (CA)
- Oregon Health & Science University (US)
- University of Chicago (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2024-11-26
- DOI
- https://doi.org/10.1002/alz.14168
- Citations
- 6
- Primary Topic
- Neurobiology of Language and Bilingualism
- Type
- article
- Field-Weighted Citation Impact
- 2.06
Funders
- National Institutes of Health
- National Institute on Aging